medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 8.71
-0.16 (-1.80%)
Aug 21, 2026, 5:31 PM CET
medmix AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 437 | 448 | 483.9 | 486.6 | 477.1 | 457.3 | |
Revenue Growth | -6.64% | -7.42% | -0.56% | 1.99% | 4.33% | 30.17% |
Cost of Revenue | 276.5 | 286.1 | 324.2 | 328.9 | 304.3 | 276.1 |
Gross Profit | 160.5 | 161.9 | 159.7 | 157.7 | 172.8 | 181.2 |
Selling, General & Admin | 112.5 | 114.9 | 116.4 | 119 | 103 | 95.6 |
Research & Development | 20.6 | 19.6 | 25.4 | 25.7 | 23.6 | 23 |
Other Operating Expenses | -1.5 | -1.6 | -1.3 | -4.3 | 5.4 | -0.2 |
Operating Expenses | 131.6 | 132.9 | 140.5 | 140.4 | 132 | 118.4 |
Operating Income | 28.9 | 29 | 19.2 | 17.3 | 40.8 | 62.8 |
Interest Expense | -13.8 | -10.7 | -12.1 | -10 | -6.5 | -8.1 |
Interest & Investment Income | 1.4 | 1.3 | 1.1 | 1.3 | 0.7 | - |
Earnings From Equity Investments | - | - | -5.7 | - | - | - |
Currency Exchange Gain (Loss) | 5.9 | -3.2 | -1.4 | -2.5 | -4.5 | -3.3 |
Other Non Operating Income (Expenses) | -9.6 | -2.3 | -0.9 | -1.3 | 0.2 | -0.3 |
EBT Excluding Unusual Items | 12.8 | 14.1 | 0.2 | 4.8 | 30.7 | 51.1 |
Merger & Restructuring Charges | -6 | -3.2 | -2.2 | -0.9 | -1.6 | -0.3 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 1.3 |
Gain (Loss) on Sale of Assets | 0.2 | 0.2 | 0.8 | 2 | -15.4 | 0.1 |
Asset Writedown | -5.6 | -3.1 | -5.2 | -3 | -1.5 | -0.9 |
Legal Settlements | - | 0.9 | - | - | - | - |
Pretax Income | 1.4 | 8.9 | -6.4 | 2.9 | 12.2 | 51.3 |
Income Tax Expense | 0.5 | 1.9 | - | 2.2 | 0.6 | 7.3 |
Earnings From Continuing Operations | 0.9 | 7 | -6.4 | 0.7 | 11.6 | 44 |
Minority Interest in Earnings | -0.8 | -0.6 | -1 | -0.4 | - | - |
Net Income | 0.1 | 6.4 | -7.4 | 0.3 | 11.6 | 44 |
Net Income to Common | 0.1 | 6.4 | -7.4 | 0.3 | 11.6 | 44 |
Net Income Growth | - | - | - | -97.41% | -73.64% | 358.33% |
Shares Outstanding (Basic) | 46 | 41 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 46 | 42 | 41 | 41 | 41 | 41 |
Shares Change | 12.25% | 0.24% | 0.50% | 0.25% | -0.15% | 20.14% |
EPS (Basic) | 0.00 | 0.16 | -0.18 | 0.01 | 0.28 | 1.07 |
EPS (Diluted) | -0.00 | 0.15 | -0.18 | 0.01 | 0.28 | 1.07 |
EPS Growth | - | - | - | -97.38% | -73.81% | 281.77% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 31.7 | 33.3 | 48.1 | 9.7 | 11.2 | 57.5 |
Free Cash Flow Per Share | 0.69 | 0.80 | 1.16 | 0.23 | 0.27 | 1.40 |
Dividend Per Share | 0.100 | 0.100 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Growth | -80.00% | -80.00% | 0% | 0% | 0% | - |
Gross Margin | 36.73% | 36.14% | 33.00% | 32.41% | 36.22% | 39.62% |
Operating Margin | 6.61% | 6.47% | 3.97% | 3.55% | 8.55% | 13.73% |
Profit Margin | 0.02% | 1.43% | -1.53% | 0.06% | 2.43% | 9.62% |
Free Cash Flow Margin | 7.25% | 7.43% | 9.94% | 1.99% | 2.35% | 12.57% |
EBITDA | 71.6 | 72.9 | 68 | 60.8 | 80.2 | 105 |
EBITDA Margin | 16.38% | 16.27% | 14.05% | 12.50% | 16.81% | 22.96% |
D&A For EBITDA | 42.7 | 43.9 | 48.8 | 43.5 | 39.4 | 42.2 |
EBIT | 28.9 | 29 | 19.2 | 17.3 | 40.8 | 62.8 |
EBIT Margin | 6.61% | 6.47% | 3.97% | 3.55% | 8.55% | 13.73% |
Effective Tax Rate | 35.71% | 21.35% | - | 75.86% | 4.92% | 14.23% |